Merck has announced that the European Commission has approved an update to the Erbitux (cetuximab) EU label, extending its ...
Eisai and Biogen have announced that the U.S. Food and Drug Administration has approved a supplemental biologics licence application for a once weekly subcutaneous initiation dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results